| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/14/2001 | EP1075528A1 Endothelin-converting-enzyme like protein |
| 02/14/2001 | EP1075527A2 Triacylglycerol lipases |
| 02/14/2001 | EP1075526A1 Putative lactamase proteins from mouse and human |
| 02/14/2001 | EP1075525A1 Dna polymerase from pyrobaculum islandicum |
| 02/14/2001 | EP1075524A2 Attenuated influenza viruses |
| 02/14/2001 | EP1075523A2 Structural proteins of fish pancreatic disease virus and uses thereof |
| 02/14/2001 | EP1075522A2 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 02/14/2001 | EP1075521A2 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/14/2001 | EP1075520A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate |
| 02/14/2001 | EP1075519A2 Inhibitors of nf-kb activation |
| 02/14/2001 | EP1075518A2 Human transcriptional regulator molecules |
| 02/14/2001 | EP1075517A1 Chimeric receptors |
| 02/14/2001 | EP1075516A2 Human proteins having transmembrane domains and dnas encoding these proteins |
| 02/14/2001 | EP1075515A1 Method for prolonged storage of dna molecules and packaging implementing said method |
| 02/14/2001 | EP1075514A1 Modifying the expression of the fsh beta gene by homologous recombination |
| 02/14/2001 | EP1075513A1 Continuous in vitro evolution |
| 02/14/2001 | EP1075512A2 Cytotoxin-based biological containment |
| 02/14/2001 | EP1075510A1 Novel rhamnogalacturonan hydrolases |
| 02/14/2001 | EP1075508A2 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075495A1 Gprw receptor |
| 02/14/2001 | EP1075494A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075492A1 Melanocortin 1 receptor selective compounds |
| 02/14/2001 | EP1075490A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 02/14/2001 | EP1075486A1 Method of treating bladder and lower urinary tract syndromes |
| 02/14/2001 | EP1075283A1 A process of delivering a polynucleotide to a cell via the vascular system |
| 02/14/2001 | EP1075275A1 Use of interleukin-18 as vaccine adjuvant |
| 02/14/2001 | EP1075273A2 Inhibiton of helicobacter pylori proliferation |
| 02/14/2001 | EP0983380A4 Methods for treating bipolar mood disorder associated with markers on chromosome 18q |
| 02/14/2001 | EP0968226A4 G-rich oligo aptamers and methods of modulating an immune response |
| 02/14/2001 | EP0851932B1 Plasmid stabilization |
| 02/14/2001 | EP0849990B1 Quiescent cell populations for nuclear transfer |
| 02/14/2001 | EP0618924B1 Hbv amplifier probes for use in solution phase sandwich hybridization assays |
| 02/14/2001 | EP0576590B1 Response element compositions and assays employing same |
| 02/14/2001 | CN1284168A Solid-phase tips and uses relating thereto |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284133A DNA molecules conferring dalapon-resistance to plants and plants transformed thereby |
| 02/14/2001 | CN1284132A Method for prodn of glycerol by recombinant organisms |
| 02/14/2001 | CN1284131A Human tyroid protein ZSIG45 and data encoding same |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/14/2001 | CN1284129A Thermostable glucoamylase |
| 02/14/2001 | CN1284128A Sex-speific insemination of mammals with low number of sperm cells |
| 02/14/2001 | CN1284085A Frozen foodstuff |
| 02/14/2001 | CN1284083A Tumor antigen peptide derivatives |
| 02/14/2001 | CN1284082A Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics |
| 02/14/2001 | CN1283997A Keratinocyte growth factor-2 formulations |
| 02/14/2001 | CN1283702A Process for prepn. naturally foled and secreted protein through co-secretion of molecular partner |
| 02/14/2001 | CN1283699A Multi-expression kit for multiple promoters contained in methanol yeast expression system |
| 02/14/2001 | CN1283698A Co-expression of trisaccharide phosphate isomerase, fructose-1,6-bisphosphate aldolase and fructose-1,6-bisphosphatase |
| 02/14/2001 | CN1283697A Secretion-type bacterial strain with chloromycetin resistance to generate glutary-7-aminocephalophytenic acid acylase with high output |
| 02/14/2001 | CN1283696A Secretion-type bacterial strain to generate glutaryl-7-aminocephalophytenic acid acylase with high output |
| 02/14/2001 | CN1283695A Gene associated with esophagus cancer |
| 02/14/2001 | CN1283694A Gene associated with esophagus cancer |
| 02/14/2001 | CN1283693A Cell factor CKLF-HIA with functions of hematopoietic stimulation and immunoregulation and its variant CKLF-HIB |
| 02/14/2001 | CN1283692A Protein associated with olfaction of human nerve cell and its coding sequence |
| 02/14/2001 | CN1283631A Gene recombination human platelet factor No.4 and its new usage |
| 02/14/2001 | CN1283630A Trichosanthin mutant and its preparing process |
| 02/14/2001 | CN1062017C Plant expression carrier plasmid of phylaxin gene |
| 02/14/2001 | CN1062016C Method of preparing reorganized human sacchrified urokinasen |
| 02/14/2001 | CN1062015C Gene sequence of coded high-sweetness monellin and method for effeciency expressing said DNA sequence |
| 02/14/2001 | CN1062014C Recombinant gane coding for human alpha interon and expression vector thereof, ETC |
| 02/14/2001 | CN1061992C Colony stimulating factor for recombination of human granulocytes and medicinal compsn thereof |
| 02/13/2001 | US6188965 Apparatus and method for automated protein design |
| 02/13/2001 | US6188788 Automatic color saturation control in video decoder using recursive algorithm |
| 02/13/2001 | US6188783 Method and system for providing a probe array chip design database |
| 02/13/2001 | US6187996 Plant promoter comprising a G-box element, GCCACGTGCC or GCCACGTGAG, and an application thereof |
| 02/13/2001 | US6187995 Method for producing disease resistant plant with thionin gene from Avena sativa |
| 02/13/2001 | US6187994 Compositions and methods for genetic modification of plants |
| 02/13/2001 | US6187993 Transgenic animals as model of psoriasis |
| 02/13/2001 | US6187992 Transgenic mouse having a disrupted amyloid precursor protein gene |
| 02/13/2001 | US6187991 Transgenic animal models for type II diabetes mellitus |
| 02/13/2001 | US6187913 Covalently crosslinked oligonucleotides, preparation method and synthon which is of use in the method |
| 02/13/2001 | US6187908 Tubby 2 polypeptides |
| 02/13/2001 | US6187904 Amino acid sequences of microbiocidal proteins; for transgenic plants with increased disease resistance |
| 02/13/2001 | US6187760 Cationic phospholipids for transfection |
| 02/13/2001 | US6187759 Canine parvovirus DNA vaccination |
| 02/13/2001 | US6187757 Regulation of biological events using novel compounds |
| 02/13/2001 | US6187751 Biologically active peptide of ob protein |
| 02/13/2001 | US6187749 Methods for variation of chromatin condensation |
| 02/13/2001 | US6187748 Treatment and prevention of hiv |
| 02/13/2001 | US6187732 The variant cellulases have replacements at sensitive residues to improve stability and/or performance. |
| 02/13/2001 | US6187589 Vectorial cloning system of DNA |
| 02/13/2001 | US6187588 Exposing cells to inhibitor of apoptosis |
| 02/13/2001 | US6187587 Nucleotide sequences; for diagnosis and treatment of related disorders |
| 02/13/2001 | US6187586 Nucleotide sequence of compound which inhibits expression of human serine/threonine kinase involved in signal transduction; diagnosis, prophylaxis, and therapy of related diseases |
| 02/13/2001 | US6187585 Oligonucleotide inhibition of epidermal growth factor receptor expression |
| 02/13/2001 | US6187584 Products and processes for regulation of gene recombination |
| 02/13/2001 | US6187579 Customized proteases |
| 02/13/2001 | US6187578 Carboxypeptidases and nucleic acids encoding the same |
| 02/13/2001 | US6187577 Cellulase producing Actinomycetes cellulase produced therefrom and method of producing same |
| 02/13/2001 | US6187575 Thermolabile uracil-DNA-glycosylas, process for its preparation and use for removing uracil from DNA |
| 02/13/2001 | US6187574 Process for producing the enzyme D-amino acid oxidase of Rhodotorula gracilis in host cells |
| 02/13/2001 | US6187573 DNA encoding a thermostable DNA polymerase |
| 02/13/2001 | US6187571 Transforming plant cells with dna sequence coding for oxalate oxidase of defined amino acid sequence, then selecting plants which express this enzyme; disease resistant, transgenic plants |
| 02/13/2001 | US6187567 Methods and reagents for in situ amplification |
| 02/13/2001 | US6187564 Nucleotide sequences coding a fusion protein; for the proliferation, differentiation and activation of hematopoietic stem cells; for treatment of cancers; anticarcinogenic agents |
| 02/13/2001 | US6187562 Polynucleotides encoding human sphingosine Lyase |
| 02/13/2001 | US6187561 Nucleotide sequence coding enzymatic polypeptide associated with charging molecule during translation; for detection of bactericides; for antibiotic prophylaxis before dental treatment; for prevention of infections; wound healing agents |
| 02/13/2001 | US6187560 Nucleotide sequences coding mitochondrial polypeptide; for the treatment of dietetics, diabetes, hyperlipidemia and weight defects |